James Hamilton
Company: Arrowhead Pharmaceuticals, Inc.
Job title: Senior Vice President & Chief - Discovery & Translational Medicine Development
Seminars:
Targeting Complement Factor B with siRNA: Concept to Clinic 11:15 am
Lessons learned from discovery and early preclinical complement inhibitor studies Using Complement Factor B inhibitors to target the alternative pathway Evaluating safety, tolerability, PK/PD in C3 and Factor B inhibitors to treat renal diseaseRead more
day: Conference Day One